PROCTER & GAMBLE HEALTH | NATURAL CAPS | PROCTER & GAMBLE HEALTH/ NATURAL CAPS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 45.8 | 75.6% | View Chart |
P/BV | x | 10.6 | 2.7 | 391.7% | View Chart |
Dividend Yield | % | 2.0 | 0.3 | 714.0% |
PROCTER & GAMBLE HEALTH NATURAL CAPS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
NATURAL CAPS Mar-23 |
PROCTER & GAMBLE HEALTH/ NATURAL CAPS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 679 | 790.2% | |
Low | Rs | 3,883 | 374 | 1,038.2% | |
Sales per share (Unadj.) | Rs | 740.7 | 184.4 | 401.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 19.7 | 700.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 27.4 | 565.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.00 | 9,500.0% | |
Avg Dividend yield | % | 2.1 | 0.2 | 1,081.6% | |
Book value per share (Unadj.) | Rs | 447.6 | 131.8 | 339.6% | |
Shares outstanding (eoy) | m | 16.60 | 9.35 | 177.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.9 | 218.6% | |
Avg P/E ratio | x | 33.5 | 26.7 | 125.4% | |
P/CF ratio (eoy) | x | 29.8 | 19.2 | 155.3% | |
Price / Book Value ratio | x | 10.3 | 4.0 | 258.6% | |
Dividend payout | % | 68.7 | 5.1 | 1,355.9% | |
Avg Mkt Cap | Rs m | 76,761 | 4,922 | 1,559.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 95 | 2,167.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,724 | 713.3% | |
Other income | Rs m | 184 | 16 | 1,137.3% | |
Total revenues | Rs m | 12,480 | 1,740 | 717.3% | |
Gross profit | Rs m | 3,247 | 343 | 946.3% | |
Depreciation | Rs m | 281 | 72 | 389.8% | |
Interest | Rs m | 8 | 37 | 20.7% | |
Profit before tax | Rs m | 3,142 | 250 | 1,257.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 65 | 1,294.2% | |
Profit after tax | Rs m | 2,295 | 184 | 1,244.0% | |
Gross profit margin | % | 26.4 | 19.9 | 132.7% | |
Effective tax rate | % | 27.0 | 26.2 | 103.0% | |
Net profit margin | % | 18.7 | 10.7 | 174.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,015 | 1,153.9% | |
Current liabilities | Rs m | 6,791 | 669 | 1,014.4% | |
Net working cap to sales | % | 40.0 | 20.1 | 199.6% | |
Current ratio | x | 1.7 | 1.5 | 113.7% | |
Inventory Days | Days | 263 | 6 | 4,453.3% | |
Debtors Days | Days | 343 | 1,104 | 31.1% | |
Net fixed assets | Rs m | 10,617 | 1,873 | 567.0% | |
Share capital | Rs m | 166 | 93 | 179.0% | |
"Free" reserves | Rs m | 7,265 | 1,140 | 637.5% | |
Net worth | Rs m | 7,431 | 1,232 | 603.0% | |
Long term debt | Rs m | 0 | 704 | 0.0% | |
Total assets | Rs m | 22,330 | 2,888 | 773.3% | |
Interest coverage | x | 409.1 | 7.7 | 5,309.5% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 92.2% | |
Return on assets | % | 10.3 | 7.7 | 134.3% | |
Return on equity | % | 30.9 | 15.0 | 206.3% | |
Return on capital | % | 42.4 | 14.8 | 285.8% | |
Exports to sales | % | 0 | 15.0 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 258 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 258 | 567.5% | |
Fx outflow | Rs m | 1,605 | 140 | 1,144.1% | |
Net fx | Rs m | -140 | 118 | -118.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 172 | 1,370.7% | |
From Investments | Rs m | -215 | -1,046 | 20.5% | |
From Financial Activity | Rs m | -985 | 875 | -112.5% | |
Net Cashflow | Rs m | 1,160 | 1 | 146,873.4% |
Indian Promoters | % | 0.0 | 56.6 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 1.3 | 1,524.4% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 43.4 | 110.9% | |
Shareholders | 56,778 | 10,954 | 518.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | NATURAL CAPS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.40% | 0.45% |
1-Month | -1.15% | 13.69% | 2.55% |
1-Year | 0.73% | -25.79% | 56.14% |
3-Year CAGR | -8.76% | 44.48% | 15.22% |
5-Year CAGR | 4.97% | 42.08% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the NATURAL CAPS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of NATURAL CAPS the stake stands at 56.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of NATURAL CAPS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
NATURAL CAPS paid Rs 1.0, and its dividend payout ratio stood at 5.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of NATURAL CAPS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.